1 October 2015
Up to 80 percent of individuals living with long-term type 1 diabetes experience gastrointestinal symptoms such as abdominal distension, irritable bowel syndrome, and fecal incontinence. A study reveals why these symptoms arise and tests an investigational drug in mice that could prevent them from developing.
http://www.sciencedaily.com/releases/2015/10/151001125647.htm
